Our products are designed to support and improve treatment outcomes in the areas of eye care, wound and skin care, nasal care and the symptoms of the common cold.
The incidence and prevalence of chronic disease is a leading cause of morbidity. At Melcare, we are experts in the development of products to help relieve some of the symptoms associated with chronic disease. Honeys from Australian and New Zealand Leptospermum spp, commonly called Manuka, a small native tree is favoured because of its well-studied compatibility in compounded products. The honey used in every individual batch is traceable to the beekeepers and forest location of the Leptospermum spp plants that produce the nectar for the honey.
Melcare President, Anthony Moloney, has been a key driver in research on products compounded with honey since 1992. Early studies helped identify which plant species were most suitable for use. Mr Moloney then developed the Medihoney® brand and product range, which were commercialised by Australia’s Capilano Honey Ltd in 1999.
Melcare Biomedical continues to drive international clinical research into the innovative products developed.
All products used by Melcare have been carefully screened and standardised to provide a consistency and compliance it the relevant international pharmaceutical standards